These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 9723044)
61. The place of botulinum toxin type A in the treatment of focal hyperhidrosis. Lowe N; Campanati A; Bodokh I; Cliff S; Jaen P; Kreyden O; Naumann M; Offidani A; Vadoud J; Hamm H Br J Dermatol; 2004 Dec; 151(6):1115-22. PubMed ID: 15606505 [TBL] [Abstract][Full Text] [Related]
62. Tumescent suction curettage in the treatment of axillary hyperhidrosis: experience in 63 patients. Boni R Dermatology; 2006; 213(3):215-7. PubMed ID: 17033170 [TBL] [Abstract][Full Text] [Related]
63. Treatment of hyperhidrosis with botulinum toxin. Glogau RG Dermatol Clin; 2004 Apr; 22(2):177-85, vii. PubMed ID: 15222578 [TBL] [Abstract][Full Text] [Related]
64. Botulinum toxin type A vs type B for axillary hyperhidrosis in a case series of patients observed for 6 months. Frasson E; Brigo F; Acler M; Didonè G; Vicentini S; Bertolasi L Arch Dermatol; 2011 Jan; 147(1):122-3. PubMed ID: 21242408 [No Abstract] [Full Text] [Related]
65. Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival. Campanati A; Sandroni L; Gesuita R; Giuliano A; Giuliodori K; Marconi B; Ganzetti G; Offidani A J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):917-21. PubMed ID: 21054569 [TBL] [Abstract][Full Text] [Related]
66. Treatment of axillary hyperhidrosis by chemodenervation of sweat glands using botulinum toxin type A. Glaser DA J Drugs Dermatol; 2004; 3(6):627-31. PubMed ID: 15624745 [TBL] [Abstract][Full Text] [Related]
67. Repetitive injections of botulinum toxin A continuously increase the duration of efficacy in primary axillary hyperhidrosis: a retrospective analysis in 101 patients. Brehmer F; Lockmann A; Grönemeyer LL; Kretschmer L; Schön MP; Thoms KM J Dtsch Dermatol Ges; 2015 Aug; 13(8):799-805. PubMed ID: 26176740 [TBL] [Abstract][Full Text] [Related]
68. Pressure-and dose-controlled, needle-free, transcutaneous pneumatic injection of botulinum neurotoxin-A for the treatment of primary axillary and palmoplantar hyperhidrosis. Kim HM; Lee MJ; Lee MH; Lee H Skin Res Technol; 2020 Jul; 26(4):577-583. PubMed ID: 31922304 [TBL] [Abstract][Full Text] [Related]
69. Reconstituted and frozen botulinum toxin A is as effective and safe as fresh for treating axillary hyperhidrosis: A retrospective study. Shayesteh A; Boman A; Hawas E; Carlberg B PLoS One; 2023; 18(12):e0295393. PubMed ID: 38048338 [TBL] [Abstract][Full Text] [Related]
70. Botulinum toxin type A therapy for palmar and digital hyperhidrosis. Solomon BA; Hayman R J Am Acad Dermatol; 2000 Jun; 42(6):1026-9. PubMed ID: 10827408 [TBL] [Abstract][Full Text] [Related]
71. [Axillary hyperhidrosis: successful treatment with botulinum toxin A]. Heckmann M; Breit S; Ceballos-Baumann A; Schaller M; Plewig G Hautarzt; 1998 Feb; 49(2):101-3. PubMed ID: 9551330 [TBL] [Abstract][Full Text] [Related]
72. Treatment of compensatory hyperhidrosis with botulinum toxin type A. Belin EE; Polo J Cutis; 2003 Jan; 71(1):68-70. PubMed ID: 12553633 [TBL] [Abstract][Full Text] [Related]
73. High-dose injection of botulinum toxin to treat focal hyperhidrosis: what's wrong with the concept? Naumann M; Hamm H J Am Acad Dermatol; 2004 Feb; 50(2):326-7. PubMed ID: 14726900 [No Abstract] [Full Text] [Related]
74. Skin cooling for botulinum toxin A injection in patients with focal axillary hyperhidrosis: a prospective, randomized, controlled study. Bechara FG; Sand M; Altmeyer P; Sand D; Hoffmann K Ann Plast Surg; 2007 Mar; 58(3):299-302. PubMed ID: 17471136 [TBL] [Abstract][Full Text] [Related]
75. Use of a transparent dressing in the treatment of axillary hyperhidrosis with botulinum toxin type A. Galán-Gutiérrez M; Garnacho-Saucedo G; Salido-Vallejo R; Vélez Garcia-Nieto A; Moreno-Giménez JC J Am Acad Dermatol; 2010 Dec; 63(6):e111-2. PubMed ID: 21093655 [No Abstract] [Full Text] [Related]
76. Botulinum toxin A for palmar hyperhidrosis. Wollina U; Karamfilov T J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):555-8. PubMed ID: 11843216 [TBL] [Abstract][Full Text] [Related]
77. Palmar hyperhidrosis in a 13-year-old boy: treatment with botulinum toxin A. Vázquez-López ME; Pego-Reigosa R Clin Pediatr (Phila); 2005; 44(6):549-51. PubMed ID: 16015405 [No Abstract] [Full Text] [Related]
78. Botulinum toxin A injections in the treatment of axillary hyperhidrosis: a prospective study reviewing quality of life and patient satisfaction in a UK tertiary dermatology centre. Asfour L; Moussa A; Littlewood Z; Sharif J; Newsham J; O'Donoghue N; Ogden S; McMullen E; Hunter H Clin Exp Dermatol; 2022 Jul; 47(7):1358-1359. PubMed ID: 35262223 [No Abstract] [Full Text] [Related]
79. Intradermal botulinum A toxin injection for axillary hyperhydrosis. Farrugia MK; Nicholls EA J Pediatr Surg; 2005 Oct; 40(10):1668-9. PubMed ID: 16227006 [TBL] [Abstract][Full Text] [Related]
80. A close positive correlation between malodor and sweating as a marker for the treatment of axillary bromhidrosis with Botulinum toxin A. He J; Wang T; Dong J J Dermatolog Treat; 2012 Dec; 23(6):461-4. PubMed ID: 21801111 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]